COPD Insights for Primary Care: 5 New Studies

News
Slideshow

Findings: Don’t blame patients for all inhaler-use errors; singing may help improve breathing, QOL; Rx adherence does improve over time; plus 3 more outcomes of interest.

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Recent Videos
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Related Content
Digital Asthma Program Improves Symptom Control in Adults: Daily Dose / image credit: ©New Africa/AdobeStock

Digital Asthma Program Improves Symptom Control in Adults: Daily Dose

Sydney Jennings
August 11th 2025
Article
Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
August 11th 2025
Podcast
Roche's Investigational Anti-IL-33/ST2 Antibody / image credit ©Sundry Photography/stock.adobe.com

Roche's Investigational Anti-IL-33/ST2 Antibody for COPD Misses Phase 3 Primary Endpoint

Grace Halsey
August 11th 2025
Article
NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

Sydney Jennings
August 11th 2025
Podcast
Upstream Bio's TSLP Antagonist Verekitug Enters Global Phase 2 Trial for COPD / image credit courtesy of Upstream Bio

Upstream Bio's TSLP Antagonist Verekitug Enters Global Phase 2 Trial for COPD

Grace Halsey
August 11th 2025
Article
Circulating Inflammatory Cells Persist in Severe Asthma Despite Biologic Therapy, Study Shows / image courtesy of Karolinska Institutet

Circulating Inflammatory Cells Persist in Severe Asthma Despite Biologic Therapy, Study Shows

Grace Halsey
August 11th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.